These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6091231)

  • 1. [Use of acyclovir in the prevention of herpes infections after allogenic bone marrow grafts].
    Gluckman E; Lotsberg J; Devergie A; Zhao XM; Melo R; Gomez-Morales M; Mazeron MC; Pérol Y
    Rev Fr Transfus Immunohematol; 1984 Jun; 27(3):391-6. PubMed ID: 6091231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral acyclovir prophylactic treatment of herpes simplex infection after bone marrow transplantation.
    Gluckman E; Lotsberg J; Devergie A; Zhao XM; Melo R; Gomez-Morales M; Mazeron MC; Perol Y
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():161-7. PubMed ID: 6313595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis of herpes infections after bone-marrow transplantation by oral acyclovir.
    Gluckman E; Lotsberg J; Devergie A; Zhao XM; Melo R; Gomez-Morales M; Nebout T; Mazeron MC; Perol Y
    Lancet; 1983 Sep; 2(8352):706-8. PubMed ID: 6136841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of acyclovir for prophylaxis of herpes infections in severely immunocompromised patients.
    Prentice HG
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():153-9. PubMed ID: 6313594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyclovir prophylaxis of herpes-simplex-virus infections.
    Saral R; Burns WH; Laskin OL; Santos GW; Lietman PS
    N Engl J Med; 1981 Jul; 305(2):63-7. PubMed ID: 6264292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group.
    Prentice HG; Gluckman E; Powles RL; Ljungman P; Milpied N; Fernandez Rañada JM; Mandelli F; Kho P; Kennedy L; Bell AR
    Lancet; 1994 Mar; 343(8900):749-53. PubMed ID: 7907729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation.
    Meyers JD; Reed EC; Shepp DH; Thornquist M; Dandliker PS; Vicary CA; Flournoy N; Kirk LE; Kersey JH; Thomas ED
    N Engl J Med; 1988 Jan; 318(2):70-5. PubMed ID: 2827025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
    Engelhard D; Morag A; Or R; Naparstek E; Cividalli G; Ruchlemer R; Aker M; Maayan S; Slavin S
    Isr J Med Sci; 1988 Mar; 24(3):145-50. PubMed ID: 3286577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation--a randomized double-blind placebo-controlled study.
    Boeckh M; Kim HW; Flowers ME; Meyers JD; Bowden RA
    Blood; 2006 Mar; 107(5):1800-5. PubMed ID: 16282339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of herpesvirus infections in renal allograft recipients by low-dose oral acyclovir.
    Seale L; Jones CJ; Kathpalia S; Jackson GG; Mozes M; Maddux MS; Packham D
    JAMA; 1985 Dec; 254(24):3435-8. PubMed ID: 2999455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acyclovir prophylaxis in bone marrow transplant recipients.
    Lundgren G; Wilczek H; Lönnqvist B; Lindholm A; Wahren B; Ringdén O
    Scand J Infect Dis Suppl; 1985; 47():137-44. PubMed ID: 3006228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation.
    Selby PJ; Powles RL; Easton D; Perren TJ; Stolle K; Jameson B; Fiddian AP; Tryhorn Y; Stern H
    Br J Cancer; 1989 Mar; 59(3):434-8. PubMed ID: 2539180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts.
    Balfour HH; Chace BA; Stapleton JT; Simmons RL; Fryd DS
    N Engl J Med; 1989 May; 320(21):1381-7. PubMed ID: 2541335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation.
    Burns LJ; Miller W; Kandaswamy C; DeFor TE; MacMillan ML; Van Burik JA; Weisdorf DJ
    Bone Marrow Transplant; 2002 Dec; 30(12):945-51. PubMed ID: 12476289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acyclovir prophylaxis for oral herpes simplex virus infection in patients with bone marrow transplants.
    Redding SW; Montgomery MT
    Oral Surg Oral Med Oral Pathol; 1989 Jun; 67(6):680-3. PubMed ID: 2544843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation.
    Wade JC; Newton B; Flournoy N; Meyers JD
    Ann Intern Med; 1984 Jun; 100(6):823-8. PubMed ID: 6326632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strong donor mononuclear cell reactivity for herpes simplex virus (HSV) antigen in HSV immune donors combined with recipient seropositivity for HSV is associated with acute graft-versus-host disease.
    Boström L; Ringdén O; Forsgren M
    Scand J Immunol; 1991 Jul; 34(1):45-52. PubMed ID: 1648786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acyclovir prophylaxis of oral herpes virus during bone marrow transplantation.
    Epstein JB; Ransier A; Sherlock CH; Spinelli JJ; Reece D
    Eur J Cancer B Oral Oncol; 1996 May; 32B(3):158-62. PubMed ID: 8762872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies in the prophylaxis of herpes infections in severely immunocompromised patients using acyclovir.
    Prentice HG; Hann IM
    Schweiz Med Wochenschr Suppl; 1983; 14():26-9. PubMed ID: 6361988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy.
    Eisen D; Essell J; Broun ER; Sigmund D; DeVoe M
    Bone Marrow Transplant; 2003 Jan; 31(1):51-5. PubMed ID: 12621507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.